Testosterone, anastrozole, factor V Leiden heterozygosity and osteonecrosis of the jaws

Blood Coagulation and Fibrinolysis

Volumn 25, Issue 3, 2014, Pages 286-288

  Pandit, Ramesh S ^a   Glueck, Charles J ^a  

^a Cholesterol and Metabolism Center   (United States)

Author keywords

Anastrozole; Anticardiolipin antibody; Deep venous thrombosispulmonary embolus; Factor V Leiden heterozygosity; Hypofibrinolysis; Methylenetetrahydrofolate reductase mutation; Osteonecrosis of jaws; Primary thrombophilia; Testosterone

Indexed keywords

ANASTROZOLE; BETA2 GLYCOPROTEIN 1; BLOOD CLOTTING FACTOR 11; BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8; CARDIOLIPIN ANTIBODY; ESTRADIOL; ESTROGEN; GESTAGEN; HOMOCYSTEINE; IMMUNOGLOBULIN M; ORAL CONTRACEPTIVE AGENT; PLASMINOGEN ACTIVATOR INHIBITOR 1; TESTOSTERONE; BLOOD CLOTTING FACTOR 5; NITRILE; TRIAZOLE DERIVATIVE;

ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; BONE BIOPSY; CARDIOLOGIST; CARDIOVASCULAR RISK; CARDIOVASCULAR STENT; CASE REPORT; DEEP VEIN THROMBOSIS; DRUG CONTRAINDICATION; DRUG WITHDRAWAL; ESTRADIOL BLOOD LEVEL; HEART INFARCTION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; JAW OSTEONECROSIS; MALE; MIDDLE AGED; PRIORITY JOURNAL; TESTOSTERONE BLOOD LEVEL; THROMBOPHILIA; X RAY ANALYSIS; BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW; BONE NECROSIS; CHEMICALLY INDUCED; GENETICS;

BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW; FACTOR V; HUMANS; MALE; MIDDLE AGED; NITRILES; OSTEONECROSIS; TESTOSTERONE; TRIAZOLES;

EID: 84897570733     PISSN: 09575235     EISSN: 14735733     Source Type: Journal    
DOI: 10.1097/MBC.0000000000000047     Document Type: Article

References (29)

1. Glueck CJ, McMahon RE, Bouquot J, Stroop D, Tracy T, Wang P, et al. Thrombophilia, hypofibrinolysis, and alveolar osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996; 81:557-566
2. Balasa VV, Gruppo RA, Glueck CJ, Wang P, Roy DR, Wall EJ, et al. Leggcalve- perthes disease and thrombophilia. J Bone Joint Surg Am 2004;2642-2647; 86-A.
3. Glueck CJ, McMahon RE, Bouquot JE, Tracy T, Sieve-Smith L, Wang P. A preliminary pilot study of treatment of thrombophilia and hypofibrinolysis and amelioration of the pain of osteonecrosis of the jaws. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998; 85:64-73
4. Glueck CJ, McMahon RE, Bouquot JE, Triplett D, Gruppo R, Wang P. Heterozygosity for the Leiden mutation of the factor V gene, a common pathoetiology for osteonecrosis of the jaw, with thrombophilia augmented by exogenous estrogens. J Lab Clin Med 1997; 130:540-543
5. Gruppo R, Glueck CJ, McMahon RE, Bouquot J. The pathophysiology of alveolar osteonecrosis of the jaw: Anticardiolipin antibodies, thrombophilia, and hypofibrinolysis. J Lab Clin Med 1996; 127:481-488
6. Glueck CJ, Freiberg RA, Boriel G, Khan Z. The role of the factor v leiden mutation in osteonecrosis of the hip. Clin Appl Thromb Hemost 2013; 19:499-503
7. Beninati F, Pruneti R, Ficarra G. Bisphosphonate-related osteonecrosis of the jaws (BRONJ). Med Oral Patol Oral Cir Bucal 2013; 18:e752-e758
8. Glueck CJ, Freiberg RA, Fontaine RN, Tracy T, Wang P. Hypofibrinolysis, thrombophilia, osteonecrosis. Clin Orthop Relat Res 2001;19-33
9. Bjorkman A, Burtscher IM, Svensson PJ, Hillarp A, Besjakov J, Benoni G. Factor V Leiden and the prothrombin 20210A gene mutation and osteonecrosis of the knee. Arch Orthop Trauma Surg 2005; 125:51-55
10. Bjorkman A, Svensson PJ, Hillarp A, Burtscher IM, Runow A, Benoni G. Factor V leiden and prothrombin gene mutation: Risk factors for osteonecrosis of the femoral head in adults. Clin Orthop Relat Res 2004;168-172
11. Bjorkman A, Jorgsholm P, Burtscher IM. Osteonecrosis of the metacarpal head in a patient with a prothrombin 20210A gene mutation. Scand J Plast Reconstr Surg Hand Surg 2005; 39:379-381
12. Glueck CJ, Richardson-Royer C, Schultz R, Burger T, Labitue F, Riaz MK, et al. Testosterone, thrombophilia, and thrombosis. Clin Appl Thromb Hemost 2013; epub 4/26/13
13. Glueck CJ, Goldenberg N, Budhani S, Lotner D, Abuchaibe C, Gowda M, et al. Thrombotic events after starting exogenous testosterone in men with previously undiagnosed familial thrombophilia. Transl Res 2011; 158:225-234
14. Glueck CJ, Bowe D, Valdez A, Wang P. Thrombosis in three postmenopausal women receiving testosterone therapy for low libido. Womens Health (Lond Engl) 2013; 9:405-410
15. Glueck CJ, Richardson-Royer C, Schultz R, Burger T, Bowe D, Padda J, et al. Testosterone therapy, thrombophilia-hypofibrinolysis, and hospitalization for deep venous thrombosis-pulmonary embolus: An exploratory, hypothesis-generating study. Clin Appl Thromb Hemost 2013; epub 8/9/13
16. Ridker PM, Miletich JP, Hennekens CH, Buring JE. Ethnic distribution of factor V Leiden in 4047 men and women. Implications for venous thromboembolism screening. JAMA 1997; 277:1305-1307
17. Simpson ER. Sources of estrogen and their importance. J Steroid Biochem Mol Biol 2003; 86:225-230
18. Nelson LR, Bulun SE. Estrogen production and action. J Am Acad Dermatol 2001; 45:S116-S124
19. Kelly CM, Buzdar AU. Anastrozole. Expert Opin Drug Saf 2010; 9:995-1003
20. Lycette JL, Luoh SW, Beer TM, Deloughery TG. Acute bilateral pulmonary emboli occurring while on adjuvant aromatase inhibitor therapy with anastrozole: Case report and review of the literature. Breast Cancer Res Treat 2006; 99:249-255
21. Wranicz JK, Cygankiewicz I, Kula P, Walczak-Jedrzejowska R, Slowikowska-Hilczer J, Kula K. Endogenous estradiol and testosterone may predispose toward atherogenic lipid profile, but higher blood level of testosterone is associated with lower number of stenoses in the coronary arteries of men with coronary disease. Int J Biomed Sci 2006; 2:135-142
22. Glueck CJ, Freiberg RA, Sieve L, Wang P. Enoxaparin prevents progression of stages I and II osteonecrosis of the hip. Clin Orthop Relat Res 2005;164-170
23. Gohil R, Peck G, Sharma P. The genetics of venous thromboembolism. A meta-Analysis involving approximately 120 000 cases and 180 000 controls. Thromb Haemost 2009; 102:360-370
24. Akhter MS, Biswas A, Ranjan R, Meena A, Yadav BK, Sharma A, et al. Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is seen in higher frequency in the Indian patients with deep vein thrombosis. Clin Appl Thromb Hemost 2010; 16:184-188
25. Male C, Foulon D, Hoogendoorn H, Vegh P, Silverman E, David M, et al. Predictive value of persistent versus transient antiphospholipid antibody subtypes for the risk of thrombotic events in pediatric patients with systemic lupus erythematosus. Blood 2005; 106:4152-4158
26. Finkelstein JS, Lee H, Burnett-Bowie SA, Pallais JC, Yu EW, Borges LF, et al. Gonadal steroids and body composition, strength, and sexual function in men. N Engl J Med 2013; 369:1011-1022
27. Svartberg J, Braekkan SK, Laughlin GA, Hansen JB. Endogenous sex hormone levels in men are not associated with risk of venous thromboembolism: The Tromso study. Eur J Endocrinol 2009; 160:833-838
28. Cherrier MM, Matsumoto AM, Amory JK, Ahmed S, Bremner W, Paskind ER, et al. The role of aromatization in testosterone supplementation: Effects on cognition in older men. Neurology 2005; 64:290-296
29. Haring R, Travison TG, Bhasin S, Vasan RS, Wallaschofski H, Davda MN, et al. Relation between sex hormone concentrations, peripheral arterial disease, and change in ankle-brachial index: Findings from the Framingham Heart Study. J Clin Endocrinol Metab 2011; 96:3724-3732.